Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein. [electronic resource]
Producer: 20140212Description: 61-6 p. digitalISSN:- 1531-5053
- Animals
- Anthraquinones
- Bicuspid -- surgery
- Bone Density Conservation Agents -- administration & dosage
- Bone Morphogenetic Protein 2 -- pharmacology
- Bone Remodeling -- drug effects
- Collagen
- Coloring Agents
- Diphosphonates -- administration & dosage
- Dogs
- Drug Carriers
- Female
- Femur -- drug effects
- Humans
- Image Processing, Computer-Assisted -- methods
- Imidazoles -- administration & dosage
- Injections, Intravenous
- Molar -- surgery
- Osteogenesis -- drug effects
- Recombinant Proteins -- pharmacology
- Ribs -- drug effects
- Tolonium Chloride
- Tooth Extraction
- Tooth Socket -- drug effects
- Transforming Growth Factor beta -- pharmacology
- Wound Healing -- drug effects
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.